The Microbiological Profile and Antibiotic Susceptibility of Fracture Related Infections in a Low Resource Setting Differ from High Resource Settings: A Cohort Study from Cameroon
-
Published:2024-03-04
Issue:3
Volume:13
Page:236
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Fonkoue Loïc123ORCID, Tissingh Elizabeth K.45ORCID, Ngouateu Michelle Tognia6, Muluem Kennedy Olivier12, Ngongang Olivier2ORCID, Mbouyap Pretty7, Ngougni Pokem Perrin89ORCID, Fotsing Kuetche6, Bahebeck Jean2, McNally Martin10ORCID, Cornu Olivier311ORCID
Affiliation:
1. Department of Orthopedics and Trauma, Yaoundé General Hospital, Yaounde P.O. Box 5408, Cameroon 2. Department of Surgery and Specialties, University of Yaounde 1, Yaounde P.O. Box 1364, Cameroon 3. Experimental and Clinical Research Institute, Université Catholique de Louvain, 1200 Brussels, Belgium 4. Royal National Orthopedic Hospital NHS TRUST, London HA7 4LP, UK 5. King’s Global Health Partnerships, School of Life Course and Population Sciences, King’s College London, London SE1 1UL, UK 6. Department of Microbiology, Université des Montagnes, Bangante P.O. Box 208, Cameroon 7. Department of Microbiology, Centre Pasteur du Cameroun, Yaoundé P.O. Box 1274, Cameroon 8. Pharmacologie Cellulaire et Moléculaire, Louvain Drug Research Institute, Université Catholique de Louvain, 1200 Brussels, Belgium 9. Department of Microbiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 1200 Brussels, Belgium 10. Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals, Oxford OX3 7HE, UK 11. Department of Orthopedics and Trauma, Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium
Abstract
Fracture-related infection (FRI) is a common and devastating complication of orthopedic trauma in all settings. Data on the microbiological profile and susceptibility of FRI to antibiotics in low-income countries are scarce. Therefore, this study aimed to investigate the microbial patterns and antimicrobial susceptibility of FRI in a sub-Saharan African setting in order to provide guidance for the formulation of evidence-based empirical antimicrobial regimens. We conducted a retrospective analysis of patients treated for FRI with deep tissue sampling for microbiological culture from January 2016 to August 2023 in four tertiary-level hospitals in Yaoundé, Cameroon. There were 246 infection episodes in 217 patients. Cultures were positive in 209 (84.9%) cases and polymicrobial in 109 (44.3%) cases. A total of 363 microorganisms from 71 different species were identified, of which 239 (65.8%) were Gram-negative. The most commonly isolated pathogens were Staphylococcus aureus (n = 69; 19%), Enterobacter cloacae (n = 43; 11.8%), Klebsiella pneumoniae (n = 35; 9.6%), Escherichia coli (n = 35; 9.6%), and Pseudomonas aeruginosa (n = 27; 7.4%). Coagulase-negative staphylococci (CoNS) were isolated in only 21 (5.9%) cases. Gram-negative bacteria accounted for the majority of the infections in early (70.9%) and delayed (73.2%) FRI, but Gram-positive bacteria were prevalent in late FRI (51.7%) (p < 0.001). Polymicrobial infections were more frequent in the early (55.9%) and delayed (41.9%) groups than in the late group (27.6%) (p < 0.001). Apart from Staphylococcus aureus, there was no significant difference in the proportions of causative pathogens between early, delayed, and late FRI. This study found striking resistance rates of bacteria to commonly used antibiotics. MRSA accounted for 63% of cases. The most effective antibiotics for all Gram-positive bacteria were linezolid (96.4%), vancomycin (92.5%), clindamycin (85.3%), and fucidic acid (89.4%). For Gram-negative bacteria, only three antibiotics displayed a sensitivity >50%: amikacin (80.4%), imipenem (74.4%), and piperacillin + tazobactam (57%). The most effective empirical antibiotic therapy (with local availability) was the combination of vancomycin and amikacin or vancomycin and imipenem. In contrast to the literature from high-resource settings, this study revealed that in a sub-Saharan African context, Gram-negative bacteria are the most common causative microorganisms of FRI. This study revealed striking resistance rates to commonly used antibiotics, which will require urgent action to prevent antimicrobial resistance in low and middle-income countries.
Funder
Olivier Cornu, Department of Orthopedics and Trauma, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium
Reference27 articles.
1. Metsemakers, W.J., Moriarty, T.F., Morgenstern, M., Marais, L., Onsea, J., O’Toole, R.V., Depypere, M., Obremskey, W.T., Verhofstad, M.H.J., and McNally, M. (2023). The global burden of fracture-related infection: Can we do better?. Lancet Infect. Dis. 2. Outcomes of fracture-related infections—Do organism, depth of involvement, and temporality count?;Wong;J. Orthop. Surg.,2022 3. Patel, K.H., Gill, L.I., Tissingh, E.K., Galanis, A., Hadjihannas, I., Iliadis, A.D., Heidari, N., Cherian, B., Rosmarin, C., and Vris, A. (2023). Microbiological Profile of Fracture Related Infection at a UK Major Trauma Centre. Antibiotics, 12. 4. Rupp, M., Baertl, S., Walter, N., Hitzenbichler, F., Ehrenschwender, M., and Alt, V. (2021). Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study. Antibiotics, 10. 5. Recommendations for Systemic Antimicrobial Therapy in Fracture-Related Infection: A Consensus From an International Expert Group;Depypere;J. Orthop. Trauma,2020
|
|